-
Pharmacokinetics And Safety Of YA-101, A Dual Inhibitors Of D-Amino Acid Oxidase (DAAO) And NLRP3 Inflammasome, In Healthy Subjects: A Double-Blind, Placebo-Controlled, Randomized, Single Dose and Multiple Dose Phase I Study
-
Pharmacokinetics of Levodopa after Subcutaneous bolus delivery of foslevodopa/foscarbidopa
-
Pharmacological neuromodulation with intracerebroventricular administration of anaerobic dopamine for Parkinson’s disease
-
Phenomenology of Coenzyme Q10-deficiency Spinocerebellar Ataxia: Case Description Of Two Siblings And New Therapeutic Perspectives
-
Phenomenology of Functional Movement Disorders in Children
-
Phenotypic Aspects of Huntington’s Disease-Like 2 in Brazil and the World: Literature Review
-
Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease
-
Phenotypic spectrum and natural history of POLR3A-associated spastic ataxia
-
Phenotypic Variability in Combined Parkinsonism-Dystonia and Isolated Idiopathic Dystonia
-
Phenotypic variability of mitochondrial tRNA Ser(UCN) gene [MTTS1] mutation: First report from India
- « Previous Page
- 1
- …
- 125
- 126
- 127
- 128
- 129
- …
- 181
- Next Page »